Enduring CME Course: A New Horizon of Atopic Dermatitis Therapy

Activity ID

9742

Expires

July 31, 2026

Format Type

Enduring

CME Credit

2.75

Fee

CME Provider: American Academy of Allergy, Asthma & Immunology

Description of CME Course

Patients with atopic dermatitis struggle with ongoing challenges when trying to manage this chronic condition. Their symptoms can be disruptive, and some treatments can cause new problems for them to handle. Patients with skin of color often face unique challenges caused by missed diagnoses and negative side effects of traditional treatments. New therapeutic agents, including biologics and JAK inhibitors, can help these patients to manage their symptoms without the negative side effects they have experienced with other treatments, but appropriate use of these new therapies presents its own set of challenges.

A New Horizon of Atopic Dermatitis Therapy was designed by a multidisciplinary team of allergist/immunologists, dermatologists, advanced practitioners, and patients to help allergist/immunologists and dermatologists, as well as advanced practitioners and nurses working in these clinical settings, to support their patients with atopic dermatitis to navigate the new treatment options that are now available, while incorporating patients and their quality of life concerns in the process of selecting the best therapy for each patient.

ABMS Member Board Approvals by Type

Performance Improvement (PI-CME) Activity

Allergy and Immunology

More Information

Commercial Support?

Yes

NOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.

General Information on CME Activity

Educational Objectives

Determine the appropriate treatment for patients with AD
Evaluate the risks and benefits of biologics of JAK inhibitors, including their mechanisms of action, when be used in the treatment and care of patients with AD
Identify opportunities to engage the patient in developing a treatment plan for AD that addresses their unique circumstances, including quality of life and socioeconomic factors

Keywords

Atopic Dermatitis, Allergy/Immunology, Dermatology, Biologics, Shared Decision Making

Competencies

Interpersonal & Communication Skills, Medical Knowledge, Patient Care & Procedural Skills, Professionalism

CME Credit Type

AMA PRA Category 1 Credit

Practice Setting

Academic Medicine, Outpatient, Rural, Urban, VA/Military